Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 1,001–1,065 of 1,065
Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production
Ghezzal, S., Postal, B. G., Quévrain, E., Brot, L., Seksik, P., Leturque, A., Thenet, S., & Carrière, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158530 · Cited by 117
Dietary butyrate suppresses inflammation through modulating gut microbiota in high-fat diet-fed mice
Zhai, S., Qin, S., Li, L., Zhu, L., Zou, Z., & Wang, L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz153 · Cited by 101
“Endotoxin is a constituent of the outer membrane of Gramnegative bacteria, which was linked to high-fat diet-induced inflammation and metabolic disorders (Cani et al. 2008).”
BackgroundGut microbiota in health and disease: an overview focused on metabolic inflammation
Nagpal, R., Kumar, M., Yadav, A. K., Hemalatha, R., Yadav, H., Marotta, F., & Yamashiro, Y. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0062 · Cited by 97
Ryan, P. M., London, L. E. E., Bjorndahl, T. C., Mandal, R., Murphy, K., Fitzgerald, G. F., Shanahan, F., Ross, R. P., Wishart, D. S., Caplice, N. M., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0246-x · Cited by 97
“This scenario is thought to occur through increased intestinal permeability, which allows inflammatory bacterial fragments from the intestinal microbiota, such as LPS, to pass into circulation [5].”
Zhuang, P., Shou, Q., Lu, Y., Wang, G., Qiu, J., Wang, J., He, L., Chen, J., Jiao, J., & Zhang, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.003 · Cited by 94
Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences
Serino, M., Blasco-Baque, V., Nicolas, S., & Burcelin, R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0540-1 · Cited by 93
Self-citationDiet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Kang, G. G., Trevaskis, N. L., Murphy, A. J., & Febbraio, M. A. (2023) · iScience · doi:10.1016/j.isci.2022.105905 · Cited by 94
“Like a WD, several investigations have also found that consumption of an HFD increased the number of mucin-degrading Bacteroides, Faecalibacterium prausnitzii, and promoted its excessive abundance in humans.128,129 Evidence from animal models has shown that an HFD noticeably reduces Lactobacillus intestinalis but indu…”
Bidu, C., Escoula, Q., Bellenger, S., Spor, A., Galan, M., Geissler, A., Bouchot, A., Dardevet, D., Morio, B., Cani, P. D., et al. (2018) · Diabetes · doi:10.2337/db17-1488 · Cited by 90
“In addition, the modulation of gut microbiota after a high-fat diet increased intestinal permeability by reducing the expression of genes encoding tight junction (TJ) proteins such as zonula-occludens 1 (ZO-1) and occludin (3).”
BackgroundInfluentialSelf-citationNishitsuji, K., Watanabe, S., Xiao, J., Nagatomo, R., Ogawa, H., Tsunematsu, T., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34571-9 · Cited by 90
Chan, K. L., Tam, T. H., Boroumand, P., Prescott, D., Costford, S. R., Escalante, N. K., Fine, N., Tu, Y., Robertson, S. J., Prabaharan, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.027 · Cited by 88
Sexual dimorphism of cardiometabolic dysfunction: Gut microbiome in the play?
Cross, T.-W. L., Kasahara, K., & Rey, F. E. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.016 · Cited by 87
Lam, Y., Maguire, S., Palacios, T., & Caterson, I. (2017) · Nutrients · doi:10.3390/nu9060602 · Cited by 86
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
BackgroundIn Kim, H., Kim, J.-K., Kim, J.-Y., Jang, S.-E., Han, M. J., & Kim, D.-H. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.03.008 · Cited by 82
Intestinal microflora and metabolic diseases
Serino, M., Luche, E., Chabo, C., Amar, J., & Burcelin, R. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.003 · Cited by 77
Self-citationChen, Y., Lin, Y., Lin, J., Yang, N., & Chen, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700903 · Cited by 77
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Sato, H., Zhang, L. S., Martinez, K., Chang, E. B., Yang, Q., Wang, F., Howles, P. N., Hokari, R., Miura, S., & Tso, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.009 · Cited by 75
“For example, the presence of gut bacteria was found to increase intestinal permeability and inflammation associated with high-fat feeding(7,8) and the effects were abolished with antibiotic treatment.(7) Studies in our laboratory revealed that ingestion of dietary fat activates intestinal MMCs by a mechanism partially…”
BackgroundEstradiol and high fat diet associate with changes in gut microbiota in female ob/ob mice
Acharya, K. D., Gao, X., Bless, E. P., Chen, J., & Tetel, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56723-1 · Cited by 74
Garcia-Vello, P., Tytgat, H. L. P., Elzinga, J., Van Hul, M., Plovier, H., Tiemblo-Martin, M., Cani, P. D., Nicolardi, S., Fragai, M., De Castro, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52683-x · Cited by 74
Self-citationThe gut microbiome in anorexia nervosa: relevance for nutritional rehabilitation
Ruusunen, A., Rocks, T., Jacka, F., & Loughman, A. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5159-2 · Cited by 74
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
“Studies (Cani et al., 2007a; Cani et al., 2008) proved that metabolic endotoxemia leads to inflammatory reaction which can causes weight gain and diabetes.”
BackgroundHashemi, Z., Fouhse, J., Im, H., Chan, C., & Willing, B. (2017) · Nutrients · doi:10.3390/nu9111236 · Cited by 70
Effects of kefir or milk supplementation on zonulin in overweight subjects
Pražnikar, Z. J., Kenig, S., Vardjan, T., Bizjak, M. Č., & Petelin, A. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17696 · Cited by 69
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Childhood Obesity: Immune Response and Nutritional Approaches
Magrone, T., & Jirillo, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00076 · Cited by 67
“Increased endotoxin levels, in turn, might provoke weight gain, insulin resistance, and a higher degree of inflammation, a condition referred to as“metabolic endotoxemia,” also associated to cardiovascular disease (65).”
BackgroundPaun, A., & Danska, J. S. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12424 · Cited by 67
“Interestingly, genetically obese ob/ob mice, deficient in CD14 displayed decreased adiposity and inflammatory markers compared to their CD14-sufficient counterparts.(23)”
BackgroundInfluentialNew hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Zhong, Z., Chen, W., Gao, H., Che, N., Xu, M., Yang, L., Zhang, Y., & Ye, M. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03411-0 · Cited by 66
Crosstalk between the immune receptors and gut microbiota
Mu, C., Yang, Y., & Zhu, W. (2015) · Current Protein & Peptide Science · doi:10.2174/1389203716666150630134356 · Cited by 66
de Kloet, A. D., Pioquinto, D. J., Nguyen, D., Wang, L., Smith, J. A., Hiller, H., & Sumners, C. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.01.016 · Cited by 66
“In the case of obesity, several studies have implicated the proinflammatory effects of free fatty acids [23], leptin [24], and gut microbiota [25] as contributing mechanisms to the activation of CNS immune cells, while during hypertension, the proinflammatory actions of angiotensin-II (Ang-II) have received much atten…”
Short-term dietary changes can result in mucosal and systemic immune depression
Siracusa, F., Schaltenberg, N., Kumar, Y., Lesker, T. R., Steglich, B., Liwinski, T., Cortesi, F., Frommann, L., Diercks, B.-P., Bönisch, F., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01587-x · Cited by 64
Küme, T., Acar, S., Tuhan, H., Çatlı, G., Anık, A., Gürsoy Çalan, Ö., Böber, E., & Abacı, A. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3682 · Cited by 64
“Experimental studies have demonstrated a close association between intestinal permeability and the pathogenesis of obesity (12,13,14,15,16).”
BackgroundBourrie, B. C. T., Cotter, P. D., & Willing, B. P. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.039 · Cited by 64
Gut microbiome approaches to treat obesity in humans
Bianchi, F., Duque, A. L. R. F., Saad, S. M. I., & Sivieri, K. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9570-8 · Cited by 63
“In terms of genera, Cani et al. (2008) observed that when mice are treated with a high-fat diet (HFD) during 4 weeks, a reduction in the abundance of the genera Lactobacillus, Bifidobacterium and Bacteroides-Prevotella can be observed when compared to mice fed with a standard diet.”
BackgroundKaliannan, K., Wang, B., Li, X.-Y., Bhan, A. K., & Kang, J. X. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.27 · Cited by 61
“Increased Enterobacteriaceae and decreased Bifidobacterium levels are known 97 to contribute to metabolic endotoxemia and chronic low-grade inflammation (16), which are 98”
BackgroundWang, Y., Yang, J., Wang, W., Sanidad, K. Z., Cinelli, M. A., Wan, D., Hwang, S. H., Kim, D., Lee, K. S. S., Xiao, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916189117 · Cited by 59
“Previous studies have shown that the microbiota is critical for regulating gut permeability (6); therefore, it is feasible that genetic ablation or inhibition of sEH attenuates obesityinduced intestinal barrier dysfunction, in part through modulating the microbiota.”
BackgroundMethodZhu, Y., Lin, X., Li, H., Li, Y., Shi, X., Zhao, F., Xu, X., Li, C., & Zhou, G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152678 · Cited by 57
Liu, T., Wu, Y., Wang, L., Pang, X., Zhao, L., Yuan, H., & Zhang, C. (2019) · mBio · doi:10.1128/mbio.02903-18 · Cited by 56
New insights into lipopolysaccharide inactivation mechanisms in sepsis
Pérez-Hernández, E. G., Delgado-Coello, B., Luna-Reyes, I., & Mas-Oliva, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111890 · Cited by 56
The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism
Srivastava, R. K., Lutz, B., & Ruiz de Azua, I. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.867267 · Cited by 56
“Consequently, dysbiosis induced by antibiotics reduces the metabolic endotoxemia and LPS levels in obese mice, leading to improved metabolic profile (Cani et al., 2008; Figure 2).”
BackgroundInfluentialThe gut microbiota ecology: a new opportunity for the treatment of metabolic diseases ?
Burcelin, R. (2009) · Frontiers in Bioscience · doi:10.2741/3589 · Cited by 55
“Similarly, we proposed and have shown that the gut microflora from mice feeding on a fat-enriched diet was dramatically different from their chow-fed counterparts (20, 21).”
BackgroundSelf-citationHepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes
Shao, B., Munford, R. S., Kitchens, R., & Varley, A. W. (2012) · Innate Immunity · doi:10.1177/1753425912442431 · Cited by 55
Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53
Alaish, S. M., Smith, A. D., Timmons, J., Greenspon, J., Eyvazzadeh, D., Murphy, E., Shea-Donahue, T., Cirimotich, S., Mongodin, E., Zhao, A., et al. (2013) · Gut Microbes · doi:10.4161/gmic.24706 · Cited by 54
Fedirko, V., Tran, H. Q., Gewirtz, A. T., Stepien, M., Trichopoulou, A., Aleksandrova, K., Olsen, A., Tjønneland, A., Overvad, K., Carbonnel, F., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0830-8 · Cited by 50
“High exposure of the liver to these microbial products could be due to their translocation through the disrupted gut barrier, which could be a result of intestinal inflammation, chronic alcohol abuse, early phase hepatic injury, or dietary and/or lifestyle factors [24, 37, 38].”
Direct and indirect effects of lipids on microglia function
Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
Isnard, S., Lin, J., Fombuena, B., Ouyang, J., Varin, T. V., Richard, C., Marette, A., Ramendra, R., Planas, D., Raymond Marchand, L., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa338 · Cited by 51
Alam, M., Alam, Q., Kamal, M., Abuzenadah, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660151 · Cited by 47
“[28] demonstrated that a high-fat diet increased the LPS concentration in the blood by increasing the permeability of the gut, causing endotoxemia, which induce systemic inflammation in the mouse leading to obesity and diabetes.”
BackgroundResultYang, S., Li, D., Yu, Z., Li, Y., & Wu, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709629 · Cited by 40
“…effects of BBR were demonstrated in a mouse model of AS induced by HFD, a diet that has been shown to increase plasma LPS levels by modulating the composition of gut microbiota, causing intestinal barrier dysfunction and enhancing intestinal permeability (Cani et al., 2008; Cani et al., 2009).”
BackgroundThe oral microflora in obesity and type-2 diabetes
Shillitoe, E., Weinstock, R., Kim, T., Simon, H., Planer, J., Noonan, S., & Cooney, R. (2012) · Journal of Oral Microbiology · doi:10.3402/jom.v4i0.19013 · Cited by 38
“These effects are associated with elevated plasma levels of endotoxin (5), which can stimulate elevations in circulating levels of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-a) (6), causing insulin resistance (7).”
BackgroundKong, S. Y., Tran, H. Q., Gewirtz, A. T., McKeown-Eyssen, G., Fedirko, V., Romieu, I., Tjønneland, A., Olsen, A., Overvad, K., Boutron-Ruault, M.-C., et al. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0798 · Cited by 34
Vijay-Kumar, M., Vanegas, S. M., Patel, N., Aitken, J. D., Ziegler, T. R., & Ganji, V. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-16 · Cited by 29
“Antibiotic treatment reversed these effects significantly [34].”
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Ma, Y., Nenkov, M., Chen, Y., & Gaßler, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158352 · Cited by 28
Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice
Lozada-Fernández, V. V., deLeon, O., Kellogg, S. L., Saravia, F. L., Hadiono, M. A., Atkinson, S. N., Grobe, J. L., & Kirby, J. R. (2022) · mSystems · doi:10.1128/msystems.00230-21 · Cited by 23
Daniel (2020) · doi:10.1093/jn/nxaa217 · Cited by 23
Corfe, B. M., Harden, C. J., Bull, M., & Garaiova, I. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001670 · Cited by 18
Huang, M., Huang, M., Liu, L., Yang, F., He, C., Sun, Y., Jiao, Y., Tang, X., Hou, J., Chen, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202502634 · Cited by 17
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review
Hashemi, D., Fard, M. V., Mohammadhasani, K., Barati, M., & Nattagh‐Eshtivani, E. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70092 · Cited by 15
“Therefore, LPS triggers systemic and local inflammation in the body that enhances liver injury and the degree of obesity by elevating pro-inflammatory cytokine levels such as interleukin (IL)- 6, IL-1, and tumor necrosis factor α (TNF-α) (Cani et al. 2008; Roh and Seki 2013; You et al. 2005).”
Li, S., Chen, F., Zou, Y., Ning, L., Zhang, G., Zhang, S., & Yao, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-4809 · Cited by 10
Effect of Fluoride on Gut Microbiota: A Systematic Review
Yasin, M., Zohoori, F. V., Kumah, E. A., Subramanian, M., Dean, P., & Orr, C. H. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae202 · Cited by 8
Dumitru, C. N., Dumitru, A. O., Popa, G. V., Marcu, T., Ursu, M., Nechita, A., & Matei, N. M. (2026) · Dentistry Journal · doi:10.3390/dj14050289 · Cited by 6
“Excess adipose tissue produces adipokines and pro-inflammatory mediators that interact synergistically with inflammatory signals derived from the periodontium, creating a self-sustaining cycle of chronic inflammation [5,17].”
Hatton‐Jones, K. M., du Toit, E. F., & Cox, A. J. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14300 · Cited by 5
The Microbiome, Metabolism, and Networks in Precision Nutrition
Mensah, G. E., Maseng, M. G., Allard, S., & Gilbert, J. A. (2024) · Precision Nutrition · doi:10.1016/b978-0-443-15315-0.00011-0 · Cited by 2
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.